Publikationen in Zusammenarbeit mit Forschern von Instituto de Salud Carlos III (10)

2024

  1. Genomic and Immunologic Correlates in Prostate Cancer with High Expression of KLK2

    International Journal of Molecular Sciences, Vol. 25, Núm. 4

2023

  1. Mapping Immune Correlates and Surfaceome Genes in BRAF Mutated Colorectal Cancers

    Current Oncology, Vol. 30, Núm. 3, pp. 2569-2581

2022

  1. Genomic mapping of copy number variations influencing immune response in breast cancer

    Frontiers in Oncology, Vol. 12

2021

  1. Major and durable response to second-line pembrolizumab-carboplatin-paclitaxel in an oral cavity cancer patient

    Anti-Cancer Drugs, Vol. 32, Núm. 5, pp. 580-584

  2. Safety and Efficacy of Cetuximab-Based Salvage Chemotherapy After Checkpoint Inhibitors in Head and Neck Cancer

    Oncologist, Vol. 26, Núm. 6, pp. e1018-e1035

2020

  1. Increased clinical and plasma EBV DNA responses to platinum-gemcitabine after nivolumab in patients with heavily platinum-pretreated nasopharyngeal cancer

    Oral Oncology

2019

  1. Durable intracranial and extracranial response to nivolumab with appearance of secondary resistance in a heavily pretreated patient with head and neck cancer

    Head and Neck, Vol. 41, Núm. 6, pp. E86-E92

2018

  1. Novel genetic mutations detected by multigene panel are associated with hereditary colorectal cancer predisposition

    PLoS ONE, Vol. 13, Núm. 9

2017

  1. Phase II trial of dacomitinib, a pan-human EGFR tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification

    Neuro-Oncology, Vol. 19, Núm. 11, pp. 1522-1531

2015

  1. Mammographic density and breast cancer in women from high risk families

    Breast Cancer Research, Vol. 17, Núm. 1